Skip to search formSkip to main contentSkip to account menu

BMS 180048

Known as: BMS-180048 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

avitriptan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Safety Trial with the 5Ht1B/1D Agonist Avitriptan (BMS-180048) in Patients with Migraine who have Experienced Pressure, Tightness, and/or pain in the Chest, Neck, and/or throat following Sumatriptan
We investigate whether symptoms of pressure, tightness, and/or pain in the chest, neck, and/or throat after administration of the… 
1998
1998
Pharmacokinetics and Pharmacodynamics of Avitriptan in Patients With Migraine After Oral Dosing
Avitriptan (BMS‐180048) is a 5‐HT1‐like receptor agonist for the treatment of migraine. This double‐blind, placebo‐controlled… 
Review
1997
Review
1997
Acute migraine therapy: the newer drugs
In 1996, our knowledge of acute antimigraine therapy expanded in three major areas. First, large surveys have confirmed the… 
1996
1996
Monthly Update: Central & Peripheral Nervous Systems: Pharmacology of antimigraine 5-HT1D receptor agonists
The 5-HT 1D receptor agonist sumatriptan is undoubtedly a significant advance in the management of migraine and cluster attacks… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)